Optimind Pharma Corp.
OMND
CNSX
11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 210.17% | 45.02% | -50.32% | -94.80% | -95.94% |
Total Receivables | -61.96% | -50.97% | -62.86% | 38.24% | 261.98% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -15.05% | -24.18% | -54.32% | -71.74% | -77.67% |
|
|||||
Total Current Assets | -15.05% | -24.18% | -54.32% | -71.74% | -77.67% |
Net Property, Plant & Equipment | -- | -- | -- | -100.00% | -100.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -43.40% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -74.22% | -75.64% | -77.87% | -82.37% | -81.26% |
|
|||||
Total Accounts Payable | 24.01% | 342.79% | 359.35% | 162.15% | 63.31% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -78.68% | -77.03% | -76.22% | -75.00% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -62.64% | -57.49% | -25.21% | -41.05% | 607.38% |
|
|||||
Total Current Liabilities | -62.64% | -57.49% | -25.21% | -41.05% | 607.38% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -78.68% | -77.03% | -76.22% | -75.00% | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -63.12% | -62.09% | -33.83% | -48.48% | 5.38% |
|
|||||
Common Stock & APIC | 14.31% | 18.37% | 10.96% | 11.75% | -33.35% |
Retained Earnings | -17.94% | -25.08% | -27.98% | -41.14% | -65.58% |
Treasury Stock & Other | -3.17% | 0.25% | -0.42% | -- | -- |
Total Common Equity | -140.76% | -117.92% | -156.33% | -120.23% | -96.83% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -140.76% | -117.92% | -156.33% | -120.23% | -96.83% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -140.76% | -117.92% | -156.33% | -120.23% | -96.83% |
|